The European Commission has identified the use of generic and biosimilar medicines as crucial for EU health systems in report released on Friday. Detailing the potential benefits of generic and biosimilar medicines use, the European Commission identified the urgency to foster the use of biosimilar medicines specifically, an urgency heightened due to the expenditure rate…
